{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:02:57Z","timestamp":1771002177672,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bcmd.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T20:00:10Z","timestamp":1403985610000},"page":"105-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Outcome of early-treated type III Gaucher disease patients"],"prefix":"10.1016","volume":"53","author":[{"given":"Ni-Chung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siew-Lee","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiunn-Ming","family":"Sheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuu-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinn-Forng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Hang","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Chyn","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Tung","family":"Shun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2014.05.007_bb0005","doi-asserted-by":"crossref","first-page":"221-5","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0010","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","first-page":"2641","article-title":"Gaucher disease","author":"Beutler","year":"1995"},{"key":"10.1016\/j.bcmd.2014.05.007_bb0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0020","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0046-8177(95)90097-7","article-title":"Pathological findings in Gaucher disease type 2 patients following enzyme therapy","volume":"26","author":"Bove","year":"1995","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00441578","article-title":"Gaucher disease\u2014Norrbottnian type. I. General clinical description","volume":"133","author":"Dreborg","year":"1980","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2007-979754","article-title":"Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease","volume":"26","author":"Erikson","year":"1995","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.bcmd.2014.05.007_bb0035","first-page":"275-8","article-title":"Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene","volume":"47","author":"Dahl","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1203\/01.PDR.0000049515.79882.94","article-title":"Myoclonic epilepsy in Gaucher disease: genotype\u2013phenotype insights from a rare patient subgroup","volume":"53","author":"Park","year":"2003","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bcmd.2006.02.001","article-title":"Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations","volume":"36","author":"Wan","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s004399900076","article-title":"Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation","volume":"105","author":"Ida","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0060","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1212\/WNL.43.10.1993","article-title":"Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease","volume":"43","author":"Patterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bcmd.2014.05.007_bb0065","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(95)91688-1","article-title":"Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype","volume":"346","author":"Abrahamov","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2014.05.007_bb0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10545-007-0577-z","article-title":"Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases","volume":"30","author":"Davies","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymgme.2010.05.016","article-title":"Reduction in imiglucerase dosage causes immediate rise of chitotriosidase activity in patients with Gaucher disease","volume":"101","author":"Chien","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.braindev.2010.02.005","article-title":"A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients","volume":"33","author":"Kraoua","year":"2011","journal-title":"Brain Dev."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0090","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ymgme.2011.12.010","article-title":"Progressive mesenteric lymphadenopathy with protein-losing enteropathy; a devastating complication in Gaucher disease","volume":"105","author":"Lee","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0095","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10545-013-9597-z","article-title":"Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience","volume":"36","author":"Tantawy","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0100","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm.157.3.9706057","article-title":"Pulmonary manifestations of Gaucher disease: an increased risk for L444P homozygotes?","volume":"157","author":"Santamaria","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10545-011-9313-9","article-title":"Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy","volume":"34","author":"Lo","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bcmd.2007.06.015","article-title":"Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients","volume":"39","author":"Suwannarat","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0115","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-009-1164-2","article-title":"Management of neuronopathic Gaucher disease: revised recommendations","volume":"32","author":"Vellodi","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10545-008-0873-2","article-title":"Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III","volume":"31","author":"Cox-Brinkman","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2012.09.006","article-title":"Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease","volume":"50","author":"Zimran","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00247-002-0761-0","article-title":"Mesenteric mass in a young girl\u2014an unusual site for Gaucher's disease","volume":"32","author":"Lim","year":"2002","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2006.10.062","article-title":"Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy","volume":"150","author":"Burrow","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0140","doi-asserted-by":"crossref","first-page":"S27-S27","DOI":"10.1016\/j.ymgme.2012.11.045","article-title":"Abnormal pathology findings in a patient with Gaucher disease type 3 treated with enzyme replacement therapy","volume":"108","author":"Burrow","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0145","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/pbc.21948","article-title":"Giant lymphadenopathy infiltrated by Gaucher cells mimicking lymphoma","volume":"52","author":"Yagci","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2014.05.007_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/15513810601123334","article-title":"Ultrastructural features of Gaucher disease treated with enzyme replacement therapy presenting as mesenteric mass lesions","volume":"25","author":"Fowler","year":"2006","journal-title":"Fetal Pediatr. Pathol."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0155","first-page":"270","article-title":"An unusual presentation of Gaucher disease in an infant with progressive dyspnea","volume":"13","author":"Levy","year":"2013","journal-title":"Ochsner J."},{"key":"10.1016\/j.bcmd.2014.05.007_bb0160","series-title":"12th International Congress of Inborn Errors of Metabolism","first-page":"S274","article-title":"Mesenteric Gaucher cell pseudotumor \u2014 a rare cause for diarrhea and tetany in a 19year-old Gaucher's Type 3b patient","author":"Perez-Colon","year":"2013"},{"key":"10.1016\/j.bcmd.2014.05.007_bb0165","series-title":"10th European Working Group on Gaucher Disease","first-page":"37","article-title":"Mesenteric and mediastinal lymphadenopathy in Egyptian children with Gaucher disease: a study of 6 patients: can enzyme replacement therapy (ERT) play a role in improving their condition?","author":"Abdelwahab","year":"2012"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:45Z","timestamp":1761049785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979614000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1079979614000588"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.05.007","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of early-treated type III Gaucher disease patients","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}